Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schlegtendal, Anne
KIDS-STEP, NCT03474991: _Betamethasone Therapy in Hospitalised Children With CAP	Completed	3	510	Europe	Celestamine®	Julia Bielicki, Swiss National Fund for Scientific Research, University Hospital, Basel, Switzerland	Community-acquired Pneumonia	03/24	03/24
MOPAD, NCT04398758 / 2018-004762-33: Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood	Recruiting	3	360	Europe	SanaCutan Basiscreme	Infectopharm Arzneimittel GmbH, Gesellschaft für Therapieforschung mbH	Atopic Dermatitis, Infant, Newborn	12/23	06/24
CAR-CF, NCT05012306: Covid-19 Antibody Responses in Cystic Fibrosis	Active, not recruiting	N/A	500	Europe		Universitätsklinikum Köln	Cystic Fibrosis	05/24	05/24
Dillenhöfer, Stefanie
KIDS-STEP, NCT03474991: _Betamethasone Therapy in Hospitalised Children With CAP	Completed	3	510	Europe	Celestamine®	Julia Bielicki, Swiss National Fund for Scientific Research, University Hospital, Basel, Switzerland	Community-acquired Pneumonia	03/24	03/24